,,,stem cell hot play... Stem Cell Stocks Trading Under $1
Angel Biotechnology Holdings Plc (LON:ABH) Market Cap: $1.64M Angel Biotechnology Holdings Plc manufactures and supplies biomaterials for use in clinical trials through all phases of the drug development process and for product launch. Stock price: $0.09 http://www.angelbio.com
Advanced Cell Technology, Inc. (OTC:ACTC) Market Cap: $3.07M Advanced Cell Technology, Inc. develops and commercializes human embryonic and adult stem cell technology in the field of regenerative medicine. Stock price: $0.03 http://www.advancedcell.com
Aeolus Pharmaceuticals, Inc. (OTC:AOLS) Market Cap: $10.22M Aeolus Pharmaceuticals, Inc. develops catalytic antioxidant compounds for diseases and disorders of the central nervous system, respiratory system, autoimmune system and oncology. The company’s initial target applications are for the side effects of mustard gas exposure, cancer radiation therapy and amyotrophic lateral sclerosis (ALS). Stock price: $0.30 http://www.aeoluspharma.com
Aastrom Biosciences, Inc. (NASDAQ:ASTM) Market Cap: $63.76M Aastrom Biosciences, Inc. develops autologous cell products for the repair or regeneration of human tissue. Stock price: $0.48 http://www.aastrom.com/
Athersys, Inc. (NASDAQ:ATHX) Market Cap: $7.57M Athersys, Inc. develops therapeutic product candidates as treatments for obesity, damage from myocardial infarction, and conditions affecting the central nervous system. Stock price: $0.37 http://www.athersys.com
AVI BioPharma, Inc. (NASDAQ:AVII) Market Cap: $70.48M AVI BioPharma, Inc. develops therapeutic products principally based on third-generation NeuGene antisense technology. The company targets life-threatening diseases, including cardiovascular, infectious, and genetic diseases. Stock price: $0.70 http://www.avibio.com/
BrainStorm Cell Therapeutics Inc. (OTC:BCLI) Market Cap: $4.50M BrainStorm Cell Therapeutics, Inc. develops stem cell technologies as treatments for currently incurable neurodegenerative diseases. The company primarily focuses on developing NTF cells from a patient’s own bone marrow in order to treat Parkinson, ALS, and spinal cord injury. Stock price: $0.11 http://www.brainstorm-cell.com/
Cryo-Cell International, Inc. (OTC:CCEL) Market Cap: $5.89M Cryo-Cell International, Inc. engages in cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood stem cells for family use. Stock price: $0.60 http://www.cryo-cell.com/
Cell Genesys, Inc. (NASDAQ:CEGE) Market Cap: $28.35M Cell Genesys, Inc. develops and commercializes biological therapies for patients with cancer. Stock price: $0.25 http://www.cellgenesys.com
Cordlife Ltd. (PINK:CORFF) Market Cap: $- CordLife Ltd owns and operates the largest network of private cord blood banks in the Asia Pacific region. Stock price: $0.16 http://www.cordlife.com/
Curis, Inc. (NASDAQ:CRIS) Market Cap: $58.39M Curis, Inc. leverages signaling pathway drug technologies to create new medicines, primarily for cancer. Stock price: $0.79 http://www.curis.com
Forticell Bioscience, Inc. (OTC:FORB) Market Cap: $667,901.00 Forticell Bioscience, Inc. is a development stage tissue engineering company with capabilities in cell culturing, biology and biomaterials. Stock price: $0.02 http://www.forticellbioscience.com
PharmaGap Inc. (CVE:GAP) Market Cap: $4.09M PharmaGap Inc. designs and develops therapeutic drugs for the treatment of cancer and other human diseases associated with the human Protein Kinase C enzyme (PKC). PKC is expressed in abnormal levels in many types of cancer and other diseases, such as diabetes. Stock price: $0.08 http://www.pharmagap.com/
HemaCare Corporation (OTC:HEMA) Market Cap: $2.95M HemaCare Corporation collects, processes and distributes blood products to hospitals and research related organizations. It operates and manages donor centers and mobile donor vehicles to collect transfusable blood products. Additionally, HemaCare provides blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments to patients with a variety of disorders. Stock price: $0.30 http://www.hemacare.com/
International Stem Cell Corporation (OTC:ISCO) Market Cap: $8.28M International Stem Cell develops therapeutic and research products with the objective of creating an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease and retinal and corneal disease through cell transplant therapy. To assist with this, it has developed pluripotent human stem cells from unfertilized human eggs, and techniques to cause those stem cells to be “differentiated” into the specific cell types required for transplant. Stock price: $0.19 http://www.internationalstemcell.com/
ThermoGenesis Corp. (NASDAQ:KOOL) Market Cap: $26.33M ThermoGenesis Corp. designs, manufactures and markets automated and semi-automated devices and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells, wound healing proteins or growth factors from a single unit of cord blood or the patient’s own blood in less than one hour. Stock price: $0.39 http://www.thermogenesis.com/
Mesoblast Limited (ASX:MSB) Market Cap: $118.06M Mesoblast Limited commercializes adult stem cell technology aimed at the regeneration and repair of bone and cartilage. Stock price: $0.88 http://www.mesoblast.com
NeoStem, Inc. (AMEX:NBS) Market Cap: $5.57M NeoStem, Inc. operates commercial autologous adult stem cell banks. Stock price: $0.97 http://www.neostem.com/
Orchestra Therapeutics, Inc. (OTC:OCHT) Market Cap: $421,107.00 Orchestra Therapeutics, Inc., develops products to treat autoimmune and infectious diseases. Stock price: $0.03 http://www.orchestratherapeutics.com
Opexa Therapeutics, Inc. (NASDAQ:OPXA) Market Cap: $2.33M Opexa Therapeutics, Inc. develops autologous cellular therapies to treat several illnesses, including multiple sclerosis, rheumatoid arthritis, and diabetes. These therapies are based on the Company’s T-cell and adult stem cell technologies. Stock price: $0.16 http://www.opexatherapeutics.com/
Protide Pharmaceuticals, Inc. (OTC:PPMD) Market Cap: $245,777.00 Protide Pharmaceuticals, Inc. develops and commercializes technologies and processes in clinical cell therapy, transfusion medicine, cell engineering and transplantation. Stock price: $0.15 http://www.protidepharma.com
Pluristem Therapeutics Inc. (NASDAQ:PSTI) Market Cap: $7.08M Pluristem Therapeutics Inc. commercializes non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. It is developing a pipeline of products derived from human placenta. Stock price: $0.48 http://www.pluristem.com/
Stem Cell Authority Ltd. (PINK:SCAL) Market Cap: $6.53M Stem Cell Authority Ltd focuses on the collection and banking of mesenchymal stem cell technology for autologous stem cell banking. Stock price: $0.03 http://www.stemcellauthority.com/
Stem Cell Therapeutics (PINK:SCTPF) Market Cap: $7.47M Stem Cell Therapeutics Corp. develops and commercializes drug-based therapies to treat central nervous system diseases that stimulate a patient’s own resident stem cells. Stock price: $0.03 http://www.stemcellthera.com/
Titan Pharmaceuticals, Inc. (AMEX:TTP) Market Cap: $9.91M Titan Pharmaceuticals, Inc. develops therapeutics primarily for the treatment of central nervous system disorders. Stock price: $0.10 http://www.titanpharm.com/
Vitro Diagnostics, Inc. (OTC:VODG) Market Cap: $1.21M Vitro Diagnostics, Inc. develops and commercializes products derived from its human cell line research — predominantly related to diabetes. Vitro has created a patent-pending method to generate adult stem cells from tissues. The Company plans to extend their product line to include stem cell-derived human beta islet cells for use in research and drug discovery. Stock price: $0.04 http://www.vitrodiag.com/
News 
Market Data 
Discover 
AI
